FASLG and metastatic malignant neoplasm in the lymph nodes: Patients with lymph node metastases had significantly (p = 0.04) higher sFas levels, significantly (p = 0.03) lower sFasL levels and a significantly (p = 0.04) higher sFas/sFasL ratio when compared with those without lymph node involvement.